GlassScriptPhysician profile
James Mills
NPI 1912240516
$347.62
in general payments reported to CMS, 2019-2025
10 companies · $47.93 in 2025
The $47.93 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.74 · 2020: $67.45 · 2021: $34.73 · 2022: $63.36 · 2023: $36.41 · 2025: $47.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $84.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $84.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $63.43 | 2022-2025 | Interstim, Nuro |
| Cook Medical LLC | $55.30 | 2019 | |
| Boston Scientific Corporation | $41.22 | 2020-2022 | |
| Tolmar, INC. | $39.04 | 2023-2025 | Jatenzo, Eligard |
| Astellas Pharma US INC | $34.98 | 2019-2020 | |
| Dendreon Pharmaceuticals LLC | $34.73 | 2021 | |
| Pfizer INC. | $25.96 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $24.74 | 2022 | |
| Neotract INC. | $15.00 | 2020 | |
| Zyla Life Sciences, INC. | $13.22 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Mills listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.